Toumi M - Search Results

1

Benzodiazepine discontinuation with prolonged-release melatonin: hints from a German longitudinal prescription database.

Kunz D, Bineau S, Maman K, Milea D, Toumi M. Kunz D, et al. Among authors: toumi m. Expert Opin Pharmacother. 2012 Jan;13(1):9-16. doi: 10.1517/14656566.2012.638284. Epub 2011 Nov 22. Expert Opin Pharmacother. 2012. PMID: 22107732

2

Contribution of prolonged-release melatonin and anti-benzodiazepine campaigns to the reduction of benzodiazepine and Z-drugs consumption in nine European countries.

Clay E, Falissard B, Moore N, Toumi M. Clay E, et al. Among authors: toumi m. Eur J Clin Pharmacol. 2013 Apr;69(4):1-10. doi: 10.1007/s00228-012-1424-1. Epub 2012 Nov 1. Eur J Clin Pharmacol. 2013. PMID: 23114457 Free PMC article.

3

Prescription patterns of antidepressants: findings from a US claims database.

Milea D, Verpillat P, Guelfucci F, Toumi M, Lamure M. Milea D, et al. Among authors: toumi m. Curr Med Res Opin. 2010 Jun;26(6):1343-53. doi: 10.1185/03007991003772096. Curr Med Res Opin. 2010. PMID: 20373875

4

Influence of the menstrual cycle on theophylline pharmacokinetics in asthmatics.

Bruguerolle B, Toumi M, Faraj F, Vervloet D, Razzouk H. Bruguerolle B, et al. Among authors: toumi m. Eur J Clin Pharmacol. 1990;39(1):59-61. doi: 10.1007/BF02657059. Eur J Clin Pharmacol. 1990. PMID: 2276390

5

Utility decrements associated with side effects in schizophrenia.

Millier A, Amri I, Boyer L, Auquier P, Toumi M. Millier A, et al. Among authors: toumi m. J Med Econ. 2014 Dec;17(12):853-61. doi: 10.3111/13696998.2014.964405. Epub 2014 Sep 23. J Med Econ. 2014. PMID: 25211094

6

Direct healthcare cost of schizophrenia - European overview.

Kovács G, Almási T, Millier A, Toumi M, Horváth M, Kóczián K, Götze Á, Kaló Z, Zemplényi AT. Kovács G, et al. Among authors: toumi m. Eur Psychiatry. 2018 Feb;48:79-92. doi: 10.1016/j.eurpsy.2017.10.008. Epub 2018 Feb 3. Eur Psychiatry. 2018. PMID: 29428166 Review.

7

Cost effectiveness of mirabegron compared with tolterodine extended release for the treatment of adults with overactive bladder in the United Kingdom.

Aballéa S, Maman K, Thokagevistk K, Nazir J, Odeyemi IA, Hakimi Z, Garnham A, Toumi M. Aballéa S, et al. Among authors: toumi m. Clin Drug Investig. 2015 Feb;35(2):83-93. doi: 10.1007/s40261-014-0240-z. Clin Drug Investig. 2015. PMID: 25491433 Free PMC article. Clinical Trial.

8

Discretely Integrated Condition Event Simulation for Pharmacoeconomics.

Toumi M, Beck E, Sherman S, Mohseninejad L, Aballéa S. Toumi M, et al. Pharmacoeconomics. 2016 Nov;34(11):1187-1188. doi: 10.1007/s40273-016-0449-1. Pharmacoeconomics. 2016. PMID: 27637756 No abstract available.

9

A Comparison of Markov and Discrete-Time Microsimulation Approaches: Simulating the Avoidance of Alcohol-Attributable Harmful Events from Reduction of Alcohol Consumption Through Treatment of Alcohol Dependence.

Laramée P, Millier A, Brodtkorb TH, Rahhali N, Cristeau O, Aballéa S, Montgomery S, Steeves S, Toumi M, Rehm J. Laramée P, et al. Among authors: toumi m. Clin Drug Investig. 2016 Nov;36(11):945-956. doi: 10.1007/s40261-016-0442-7. Clin Drug Investig. 2016. PMID: 27470429

10

Determinants of orphan drugs prices in France: a regression analysis.

Korchagina D, Millier A, Vataire AL, Aballea S, Falissard B, Toumi M. Korchagina D, et al. Among authors: toumi m. Orphanet J Rare Dis. 2017 Apr 21;12(1):75. doi: 10.1186/s13023-016-0561-5. Orphanet J Rare Dis. 2017. PMID: 28427466 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results